AN-12855

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAN-12855
Drug Alias NameInhA inhibitor (Anacor/TB Alliance)cofactor-independent inhibitor of InhA (Anacor/TB Alliance)AN-12855
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnoyl-acyl-carrier protein reductase inhibitorsInhibin alpha chain inhibitors
TargetsInhibin alpha chainEnoyl-acyl-carrier protein reductase
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnacor Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnacor Pharmaceuticals IncTb Alliance
Active IndicationsN/A
Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A
Related LinksN/A